CD-ROM

Malaria

Presentation type		Track	Abstract category	Text
All Oral abstracts Poster Discussions Poster Exhibition CD-ROM		All A B C D	All Acute and early infection Acute and early infection and management of patients with acquired viral resistance Adherence in adults Adherence in children and adolescents Ageing AIDS related malignancies (KS, lymphoma, cervical and anal carcinoma) including HHV8 infection Animal Models Animal models of transmission, disease resistance and progression Antibody based vaccines Antiretroviral Therapies (strategic categories apply to resource rich and constrained settings) in Children and Adolescents Antiretroviral therapy,clinical trials and cohorts Antiretroviral treatment of people living with HIV for prevention Approaches to counselling and testing in children and caregivers Behavioural surveillance Bioinformatic analysis in drug resistance Bioinformatics analysis of viral diversity in natural history Blood, organ and tissue safety and nosocomial transmission Cellular immunity based vaccines Clinical trials Cohort studies Complementary and traditional medicines and the role of traditional healers in therapy Complications of Anti-Retroviral Therapy and Adherence in Adults and Children Correlates of immune protection Diagnosis of HIV disease Diagnostic Tools for the Immunological and Virological Monitoring of HIV Infection Disease burden – morbidity/mortality Epidemiology of HIV in people who use drugs Epidemiology of sexually transmitted infections (STI) and HIV Estimating the need for HIV treatment Estimating the size of HIV-infected and most at risk population Ethical issues in epidemiological research First line therapy Harm reduction, including reduction of unsafe injecting and other approaches Hepatitis co-infections: (including HBV, HCV) HIV counselling, testing and diagnostic strategies HIV diversity and epidemiology HIV Pathogenesis/Immune Function and Dysfunction HIV Pathogenesis/Latency and Viral Reservoirs HIV superinfections HIV Surveillance, Monitoring and Evaluation HIV tropism, dynamics and fitness HIV-1 and HIV-2 co-infections HIV-2 Host genetics of resistance and susceptibility Immune reconstitution disorders / IRIS Impact of nutrition Innate immunity responses and function in natural history of HIV infection Malaria Male and female condoms and other physical barriers Male circumcision Management of late presenters Measuring and modelling the effect and impact of other HIV prevention interventions Measuring and modelling the effect and impact of PMTCT Measuring and modelling the impact of the HIV epidemic Mechanisms of T cell depletion and dysfunction Methodological Issues and Capacity-Building in Epidemiology and Prevention Research Microbicides Monitoring and evaluation (other) Monitoring and evaluation of HIV prevention, care and treatment Mother to child transmission Mucosal immunity/defenses: responses and dysfunction Mucosal transmission Mycobacteria and TB Natural history, progression and survival Neurologic and psychiatric manifestations, including neurocognitive disorders New HIV testing and diagnostic strategies New monitoring strategies including rapid tests Non pathogenic models of SIV Non-AIDS related co-morbidities (e.g. diabetes, hypertension etc) Non-AIDS related malignancies Novel animal models for vaccine and inhibitor development Novel assays of immune responses Novel Treatment and Prevention Strategies Novel vectors and strategies Nucleic acid based HIV and SIV therapies Opportunistic infections (excluding mycobacterial) Other adverse reactions and complications of ARV therapy Other bacterial infections and malaria and parasitic infections Other complications Other Therapies Paediatric surveillance of HIV Pharmacogenomics Pharmacology, pharmacokinetics, drug formulations Population-based surveys with HIV testing Preclinical development of microbicides Pre-exposure and post-exposure prophylaxis Prevention addressing gender inequalities Prevention for men who have sex with men (MSM) Prevention for people living with HIV Prevention for people who use drugs Prevention for the general population Prevention in institutional settings e.g. workplace, school, prison, military Prevention of mother-to-child transmission Prophylaxis of HIV associated infections; vaccines e.g. pneumococcal, hepatitis and HPV, co-trimoxazole prophylaxis and IPT Research designs in epidemiology Sexually transmitted infections (STI) Simplification strategies (induction/maintenance and use of bPI monotherapy) STI prevention and control Surveillance of HIV (Youth and Adults) Surveillance systems and methods Switch studies Therapy for the heavily pre-treated patient Track B - Clinical Sciences Track C: Epidemiology and Prevention Sciences Transmission and Early Infection Tuberculosis Viral determinants of SIV pathogenesis Viral fitness and tropism assays, utility and application in clinical practice Viral resistance testing in clinical trials and practice Virus-specific cellular immunity When to start therapy
Late breakers only

Posters with this symbol have been selected by the Scientific Programme Committee for distinction based on merit.

Posters with this symbol have an e-Poster available.

CDA085 Abstract Age related standars for CD4+T-lymphocytes in healthy non-infected infants born to HIV -1 infected mothers in Rwanda F. Ngaboyamahina1,2 1CNLS, Kigali, Rwanda, 2ESSJTkigali, Kigali, Rwanda CDA086 Abstract The significance of molecular and genetic methods of research for HIV infection diagnostics G. Khvan, N. Dzisyuk, M. Khassanova Republic AIDS Control Center, Science, Almaty, Kazakhstan CDA087 Abstract Private and public partnership: a model for a national HIV early infant diagnosis program in Haiti B. Gautney1, N. Segaren2, S. Khamadi3 1Integral Life Foundation, Kansas City, United States, 2Caris Foundation International, Dallas, United States, 3Kenya Institute of Medical Research (KEMRI), Nairobi, Kenya CDA088 Abstract Enabling detection of infection during the window period by in-vitro antibody enhancement for reducing mother-to-child transmission and saving lives T. Jehuda-Cohen1,2, J. Mumo3 1Technion, BioMedical Engineering, Haifa, Israel, 2SMART Biotech, R&D, Rehovot, Israel, 3U. of Nairobi, Immunology, Nairobi, Kenya CDA089 Abstract Effectiveness of a district-wide programme for the prevention of mother-to-child transmission of HIV in Cambodia. Experience from six maternity units in Phnom Penh and Kandal D. Augustinova1, A. Stranska1, K. Koum2, S. Ean3, S. Vong2, C. Kong4, S. Ngin5, E. Nerrienet5, M. Bandzak1 1Magna Children at Risk, Bratislava, Slovakia, 2National Maternal and Child Health Center, Phnom Penh, Cambodia, 3Magna Children at Risk, Phnom Penh, Slovakia, 4Chey Chumneas Hospital, Takhmao, Cambodia, 5Institute Pasteur Cambodia, Phnom Penh, Cambodia CDA090 Abstract HIV-1 vertical transmission in Rio Grande, Southern Brazil: analysis of transmitted subtypes M. Tornatore1, E. Machado2,3, M.A. Soares2,4, C.V. Gonçalves1, R.A. Mendoza-Sassi1, J.M. Silveira1, N.E. D'Ávila1, M.F.M. Barral1, M.S. Bianchi1, A.M.B. Martinez1 1Universidade Federal do Rio Grande, Faculdade de Medicina, Rio Grande, Brazil, 2Universidade Federal do Rio de Janeiro, Departamento de Genética, Rio de Janeiro, Brazil, 3Universidade Federal do Rio de Janeiro, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil, 4Instituto Nacional de Câncer, Divisão de Genética, Rio Grande, Brazil